Full guidance reaffirmed. I consider the stock will take off after full year result confirmed but guidance for cash ebitda for fy17 to increase by 50 per cent
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game